update
Teva confirms US FDA warning letter for Hangzhou, China API plant
Teva Pharmaceutical Industries says the US FDA has raised concerns about its API plant in Hangzhou, China.
update
Teva Pharmaceutical Industries says the US FDA has raised concerns about its API plant in Hangzhou, China.
update
Novotech will conduct clinical trials at the 2,700-bed center with support from the medical’s center staff.
The rate of false positives in clinical trials should be set higher for certain hard-to-treat cancers, suggest researchers.
The Contract Research Biotech (CRB) is broadening its service range as it looks to secure additional long-term deals, says CFO.
UK life science companies must become global to help offset staffing and funding problems potentially caused by Brexit, says Arecor CEO Sarah Howell.
Deutsche Post DHL Group’s contract logistics business, DHL Supply Chain, has announced its intention to acquire Brazilian transport service provider Polar Transportes.